Categories
Multiple Myeloma
A Look Back at the FDA News from March 2020
A Look Back at the FDA News from March 2020 During March 2021, the FDA granted approval to 9 therapies and 1 assay across the fields of lung cancer, lymphoma, renal cell carcinoma, and gastrointestinal cancers, and more. One prospective approval chronic graft-versus-host disease was postponed by the FDA during March. Still, countless agents were […]
Read More